Centene (CNC)
(Delayed Data from NYSE)
$72.44 USD
+0.82 (1.14%)
Updated Oct 11, 2024 04:00 PM ET
After-Market: $72.43 -0.01 (-0.01%) 7:58 PM ET
4-Sell of 5 4
A Value C Growth C Momentum A VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$72.44 USD
+0.82 (1.14%)
Updated Oct 11, 2024 04:00 PM ET
After-Market: $72.43 -0.01 (-0.01%) 7:58 PM ET
4-Sell of 5 4
A Value C Growth C Momentum A VGM
Zacks News
Centene (CNC), Pyx Health Unite to Treat Mental Health Issues
by Zacks Equity Research
Centene (CNC) partners with Pyx Health to address loneliness and mental health issues among the insured.
Are You a Value Investor? This 1 Stock Could Be the Perfect Pick
by Zacks Equity Research
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Universal Health (UHS) Q4 Earnings Beat on Adjusted Admissions
by Zacks Equity Research
Universal Health (UHS) expects net revenues between $15.411 billion and $15.706 billion for 2024, which indicates 8.9% year-over-year growth.
Should SPDR Russell 1000 Low Volatility Focus ETF (ONEV) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for ONEV
Select Medical (SEM) Q4 Earnings Beat on Patient Admissions
by Zacks Equity Research
Select Medical's (SEM) Q4 results reflect strong segmental contribution, aided by higher patient days and visits. Management expects 2024 adjusted EBITDA to be $830-$880 million, up from the 2023 reported figure of $807.4 million.
Is SPDR Russell 1000 Low Volatility Focus ETF (ONEV) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for ONEV
Should Value Investors Buy Centene (CNC) Stock?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Is Centene (CNC) Stock Outpacing Its Medical Peers This Year?
by Zacks Equity Research
Here is how Centene (CNC) and Absci Corporation (ABSI) have performed compared to their sector so far this year.
Centene (CNC) to Provide Better Health Equity in North Carolina
by Zacks Equity Research
Centene (CNC) collaborates with Reinvestment Partners to improve the health of North Carolinians.
CNC or HUM: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
CNC vs. HUM: Which Stock Is the Better Value Option?
Zacks Industry Outlook Highlights Cigna, Centene and Molina Healthcare
by Zacks Equity Research
Cigna, Centene and Molina Healthcare have been highlighted in this Industry Outlook article.
The Zacks Analyst Blog Highlights AbbVie, Applied Materials, American Express, Centene and Aspen
by Zacks Equity Research
AbbVie, Applied Materials, American Express, Centene and Aspen are included in this Analyst Blog.
Top Stock Reports for AbbVie, Applied Materials & American Express
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks, including AbbVie Inc. (ABBV), Applied Materials, Inc. (AMAT) and American Express Company (AXP).
3 HMO Stocks in Focus Despite High Tech Costs & Nursing Shortage
by Debasmita Chatterjee
Growing customer base and M&A strategies are likely to aid the Medical-HMO industry. However, escalating expenses and a dearth in the availability of medical personnel are concerning. Stocks like CI, CNC and MOH are likely to navigate the industry storms.
5 Low Price-to-Book Stocks for Value Investors
by Kinjel Shah
The P/B ratio helps to identify low-priced stocks with high growth prospects. General Motors Company (GM), Cemex (CX), Centene (CNC), Enersys (ENS)) and Deutsche Bank Aktiengesellschaft (DB) are some such stocks.
5 Stocks in the S&P 500 ETF to Buy at a Bargain
by Sweta Killa
With the S&P 500 hitting new milestones, valuations are also getting lofty, making investors wary about their investments. For those, we have highlighted five stocks in the S&P 500 ETF that are undervalued, as reflected in their lower P/E ratio than industry peers.
Encompass Health (EHC) Q4 Earnings Beat on Higher Discharges
by Zacks Equity Research
Encompass Health's (EHC) Q4 results gain on improved net patient revenue per discharge and higher net income. Management estimates 2024 adjusted EPS to be $3.77-$4.06.
Tenet Healthcare (THC) Q4 Earnings Beat on Hospital Operations
by Zacks Equity Research
Tenet Healthcare (THC) expects net operating revenues to be between $19.9 billion and $20.3 billion in 2024.
Why Centene (CNC) is a Top Growth Stock for the Long-Term
by Zacks Equity Research
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Company News for Feb 7, 2024
by Zacks Equity Research
Companies in The News Are: ARCB, CNC, ATHM, LIN.
Zacks.com featured highlights Itron, EnerSys, Centene and General Motors
by Zacks Equity Research
Itron, EnerSys, Centene and General Motors have been highlighted in this Screen of The Week article.
Centene (CNC) Q4 Earnings Beat on Membership Growth, View Up
by Zacks Equity Research
Centene (CNC) expects adjusted EPS to be a minimum of $6.70 in 2024, higher than the 2023 figure of $6.68 per share.
4 Low P/CF Stocks to Navigate the Economic Landscape in 2024
by Sumit Singh
Value investing is essentially about selecting stocks that are usually cheap but fundamentally sound. ITRI, ENS, CNC & GM boast low P/CF ratios.
Centene (CNC) Reports Q4 Earnings: What Key Metrics Have to Say
by Zacks Equity Research
Although the revenue and EPS for Centene (CNC) give a sense of how its business performed in the quarter ended December 2023, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Highly Ranked Stocks to Watch as Earnings Approach
by Shaun Pruitt
Set to release their quarterly results on Tuesday, February 6, here are several standout stocks that investors will certainly want to pay attention to.